These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 25187251)

  • 1. From the Journal archives: hereditary aspects of malignant hyperthermia.
    Riazi S; Nolan K; Rosenberg H
    Can J Anaesth; 2014 Dec; 61(12):1122-5. PubMed ID: 25187251
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a novel mutation in the ryanodine receptor gene (RYR1) in patients with malignant hyperthermia.
    Rueffert H; Kraus H; Olthoff D; Deutrich C; Froster UG
    Hum Mutat; 2001 Mar; 17(3):238. PubMed ID: 11241852
    [No Abstract]   [Full Text] [Related]  

  • 3. Duchenne muscular dystrophy and malignant hyperthermia: a genetic study of the ryanodine receptor in 47 patients.
    Rohde D; Schmitt HJ; Winterpacht A; Münster T
    Eur J Anaesthesiol; 2014 Jun; 31(6):341-2. PubMed ID: 24557023
    [No Abstract]   [Full Text] [Related]  

  • 4. Continued progress in understanding the molecular genetics of malignant hyperthermia.
    Rosenberg H
    Can J Anaesth; 2011 Jun; 58(6):489-93. PubMed ID: 21455644
    [No Abstract]   [Full Text] [Related]  

  • 5. Malignant hyperthermia: a pharmacogenetic disorder.
    Stratman RC; Flynn JD; Hatton KW
    Orthopedics; 2009 Nov; 32(11):835. PubMed ID: 19902883
    [No Abstract]   [Full Text] [Related]  

  • 6. Skeletal muscle ryanodine receptor mutations associated with malignant hyperthermia showed enhanced intensity and sensitivity to triggering drugs when expressed in human embryonic kidney cells.
    Sato K; Roesl C; Pollock N; Stowell KM
    Anesthesiology; 2013 Jul; 119(1):111-8. PubMed ID: 23459219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene symbol: RYR1. Disease: malignant hyperthermia.
    Dekomien G; Gencik M; Gencikova A; Klenk Y; Epplen JT
    Hum Genet; 2005 Dec; 118(3-4):543. PubMed ID: 16521288
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene symbol: RYR1. Disease: malignant hyperthermia.
    Dekomien G; Gencik M; Gencikova A; Klenk Y; Epplen JT
    Hum Genet; 2005 Dec; 118(3-4):541. PubMed ID: 16521280
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene symbol: RYR1. Disease: malignant hyperthermia.
    Dekomien G; Gencik M; Gencikova A; Klenk Y; Epplen JT
    Hum Genet; 2005 Dec; 118(3-4):541-2. PubMed ID: 16521281
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene symbol: RYR1. Disease: malignant hyperthermia.
    Dekomien G; Gencik M; Gencikova A; Klenk Y; Epplen JT
    Hum Genet; 2005 Dec; 118(3-4):542. PubMed ID: 16521282
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene symbol: RYR1. Disease: malignant hyperthermia.
    Dekomien G; Gencik M; Gencikova A; Klenk Y; Epplen JT
    Hum Genet; 2005 Dec; 118(3-4):543. PubMed ID: 16521287
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene symbol: RYR1. Disease: malignant hyperthermia.
    Dekomien G; Gencik M; Gencikova A; Klenk Y; Epplen JT
    Hum Genet; 2005 Dec; 118(3-4):542. PubMed ID: 16521286
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene symbol: RYR1. Disease: malignant hyperthermia.
    Dekomien G; Gencik M; Gencikova A; Klenk Y; Epplen JT
    Hum Genet; 2005 Dec; 118(3-4):542. PubMed ID: 16521284
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel mutation in the RYR1 gene (R2454C) in a patient with malignant hyperthermia.
    Gencik M; Gencik A; Mortier W; Epplen JT
    Hum Mutat; 2000 Jan; 15(1):122. PubMed ID: 10612851
    [No Abstract]   [Full Text] [Related]  

  • 15. Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population.
    Kraeva N; Riazi S; Loke J; Frodis W; Crossan ML; Nolan K; Kraev A; Maclennan DH
    Can J Anaesth; 2011 Jun; 58(6):504-13. PubMed ID: 21455645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermia.
    Manning BM; Quane KA; Lynch PJ; Urwyler A; Tegazzin V; Krivosic-Horber R; Censier K; Comi G; Adnet P; Wolz W; Lunardi J; Muller CR; McCarthy TV
    Hum Mutat; 1998; 11(1):45-50. PubMed ID: 9450902
    [No Abstract]   [Full Text] [Related]  

  • 17. Myopathic changes in malignant hyperthermia-susceptible patients.
    Rosenberg H
    Can J Anaesth; 2013 Oct; 60(10):955-9. PubMed ID: 23897489
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonanesthetic malignant hyperthermia.
    Lehmann-Horn F; Klingler W; Jurkat-Rott K
    Anesthesiology; 2011 Nov; 115(5):915-7. PubMed ID: 21878807
    [No Abstract]   [Full Text] [Related]  

  • 19. The genetics of malignant hyperthermia and related muscular syndromes.
    Siracusano L; Girasole V
    Anesth Analg; 2010 Apr; 110(4):1241; author reply 1241. PubMed ID: 20357163
    [No Abstract]   [Full Text] [Related]  

  • 20. Recrudescence of malignant hyperthermia.
    Hopkins PM
    Anesthesiology; 2007 May; 106(5):893-4. PubMed ID: 17457116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.